Analysis of vitamin D status at two academic medical centers and a national reference laboratory: result patterns vary by age, gender, season, and patient location

BMC Endocrine Disorders

Matthew D Krasowski²  Emilian Racila²  Thomas C Wilson²  Jennifer T Gosselin¹  Jonathan R Genzen³ 

[1] Department of Psychology, Sacred Heart University, Fairfield, CT, USA;Department of Pathology, University of Iowa Hospitals and Clinics, Iowa City, IA, USA;Department of Pathology and Laboratory Medicine, Weill Cornell Medical College/New York Presbyterian Hospital, New York, NY, USA

关键词: UV exposure;    Cholecalciferol;    Ergocalciferol;    Calcidiol;    Hypervitaminosis D;    Vitamin D toxicity;    Vitamin D deficiency;    Vitamin D;   

Others  :  1085509
DOI  :  10.1186/1472-6823-13-52

 received in 2013-06-13, accepted in 2013-10-28,  发布年份 2013

【 摘 要 】

Background

Testing for 25-hydroxyvitamin D [25(OH)D] has increased dramatically in recent years. The present report compares overall utilization and results for 25(OH)D orders at two academic medical centers - one in New York and one in Iowa – in order to characterize the vitamin D status of our inpatient and outpatient populations. Results are also compared to those from a national reference laboratory to determine whether patterns at these two institutions reflect those observed nationally.

Methods

Retrospective data queries of 25(OH)D orders and results were conducted using the laboratory information systems at Weill Cornell Medical College / New York Presbyterian Hospital (WCMC), University of Iowa Hospitals and Clinics (UIHC), and ARUP Laboratories (ARUP). Chart review was conducted for cases with very high or low serum 25(OH)D levels in the WCMC and UIHC datasets.

Results

The majority of tests were ordered on females and outpatients. Average serum 25(OH)D levels were higher in female versus male patients across most ages in the WCMC, UIHC, and ARUP datasets. As expected, average serum 25(OH)D levels were higher in outpatients than inpatients. Serum 25(OH)D levels showed seasonal periodicity, with average levels higher in summer than winter and correlating to regional UV index. Area plots demonstrated a peak of increased 25(OH)D insufficiency / deficiency in adolescent females, although overall worse 25(OH)D status was found in male versus female patients in the WCMC, UIHC, and ARUP datasets. Surprisingly, improved 25(OH)D status was observed in patients starting near age 50. Finally, chart review of WCMC and UIHC datasets revealed over-supplementation (especially of ≥ 50,000 IU weekly doses) in the rare cases of very high 25(OH)D levels. General nutritional deficiency and/or severe illness was found in most cases of severe 25(OH)D deficiency.

Conclusions

25(OH)D status of patients seen by healthcare providers varies according to age, gender, season, and patient location. Improved 25(OH)D status was observed later in life, a finding that may reflect the previously described increased use of vitamin D-containing supplements in such populations. Severe vitamin D deficiency is much more common than vitamin D toxicity.

【 授权许可】

   
2013 Genzen et al.; licensee BioMed Central Ltd.

【 图 表 】

Figure 1.

Figure 2.

Figure 3.

Figure 4.

Figure 5.

Figure 6.

【 参考文献 】

• [1]Holick MF: Vitamin D deficiency. N Engl J Med 2007, 357(3):266-281.
• [2]Zhang R, Naughton DP: Vitamin D in health and disease: current perspectives. Nutr J 2010, 9:65. BioMed Central Full Text
• [3]Endres D, Rude R: Mineral and Bone Metabolism. In Tietz Textbook of Clinical Chemistry and Molecular Diagnostics. 4th edition. Edited by Burtis C, Ashwood E, Bruns D. St. Louis, MO: Elsevier Saunders; 2006:1920-1926.
• [4]Rollins G: Vitamin D Testing - What’s the Right Answer. Clinical Laboratory News 2009, 35(7):1-9.
• [5]Carter GD: Accuracy of 25-hydroxyvitamin D assays: confronting the issues. Curr Drug Targets 2011, 12(1):19-28.
• [6]Fraser WD, Milan AM: Vitamin D assays: past and present debates, difficulties, and developments. Calcif Tissue Int 2013, 92(2):118-127.
• [7]Janssen MJ, Wielders JP, Bekker CC, Boesten LS, Buijs MM, Heijboer AC, van der Horst FA, Loupatty FJ, van den Ouweland JM: Multicenter comparison study of current methods to measure 25-hydroxyvitamin D in serum. Steroids 2012, 77(13):1366-1372.
• [8]Roth HJ, Schmidt-Gayk H, Weber H, Niederau C: Accuracy and clinical implications of seven 25-hydroxyvitamin D methods compared with liquid chromatography-tandem mass spectrometry as a reference. Ann Clin Biochem 2008, 45(Pt 2):153-159.
• [9]Heijboer AC, Blankenstein MA, Kema IP, Buijs MM: Accuracy of 6 routine 25-hydroxyvitamin D assays: influence of vitamin D binding protein concentration. Clin Chem 2012, 58(3):543-548.
• [10]Chen Y, Kinney L, Bozovic A, Smith H, Tarr H, Diamandis EP, LeBlanc A: Performance evaluation of Siemens ADVIA Centaur and Roche MODULAR Analytics E170 Total 25-OH Vitamin D assays. Clin Biochem 2012, 45(16–17):1485-1490.
• [11]Barake M, Daher RT, Salti I, Cortas NK, Al-Shaar L, Habib RH, Fuleihan Gel H: 25-hydroxyvitamin D assay variations and impact on clinical decision making. J Clin Endocrinol Metab 2012, 97(3):835-843.
• [12]Tahsin-Swafiri S, Blanco-Navarro I, Perez-Sacristan B, Millan I, Granado-Lorencio F: The prevalence of vitamin deficiency in clinical practice is assay-dependent. Clin Nutr 2012, 31(6):1011-1014.
• [13]Krasowski MD: Pathology consultation on vitamin D testing. Am J Clin Pathol 2011, 136(4):507-514.
• [14]Looker A, Johnson C, Lacher D, Pfeiffer C, Schleicher R, Sempos C: Vitamin D Status: United States, 2001–2006. NCHS Data Brief National Center for Health Statistics 2011, 59(Hyattsville, MD):1-7.
• [15]Yetley EA: Assessing the vitamin D status of the US population. Am J Clin Nutr 2008, 88(2):558S-564S.
• [16]Holick MF, Binkley NC, Bischoff-Ferrari HA, Gordon CM, Hanley DA, Heaney RP, Murad MH, Weaver CM, Endocrine S: Evaluation, treatment, and prevention of vitamin D deficiency: an Endocrine Society clinical practice guideline. J Clin Endocrinol Metab 2011, 96(7):1911-1930.
• [17]Climate Prediction Center, National Weather Service/National Oceanic and Atmospheric Administration: Stratosphere: UV Index. http://www.cpc.ncep.noaa.gov/products/stratosphere/uv_index/ webcite
• [18]Climate Prediction Center, National Weather Service/National Oceanic and Atmospheric Administration: UV Index: Information. http://www.cpc.ncep.noaa.gov/products/stratosphere/uv_index/uv_what.shtml webcite
• [19]Zadshir A, Tareen N, Pan D, Norris K, Martins D: The prevalence of hypovitaminosis D among US adults: data from the NHANES III. Ethn Dis 2005, 15(4 Suppl 5):97-101.
• [20]Green AC, Wallingford SC, McBride P: Childhood exposure to ultraviolet radiation and harmful skin effects: epidemiological evidence. Prog Biophys Mol Biol 2011, 107(3):349-355.
• [21]Godar DE: UV doses worldwide. Photochem Photobiol 2005, 81(4):736-749.
• [22]Whiting SJ, Langlois KA, Vatanparast H, Greene-Finestone LS: The vitamin D status of Canadians relative to the 2011 Dietary Reference Intakes: an examination in children and adults with and without supplement use. Am J Clin Nutr 2011, 94(1):128-135.
• [23]Langlois K, Greene-Finestone L, Little J, Hidiroglou N, Whiting S: Vitamin D status of Canadians as measured in the 2007 to 2009 Canadian Health Measures Survey. Health Rep 2010, 21(1):47-55.
• [24]Centers for disease control and prevention: Beverage Consumption Among High School Students. MMWR 2011, 60(23):778-780.
• [25]Gahche J, Bailey R, Burt V, Hughes J, Yetley E, Dwyer J, Picciano M, McDowell M, Sempos C: Dietary Supplement Use Amoung U.S. Adults Has Increased Since NHANES III (1988–1994). NCHS Data Brief National Center for Health Statistics (Hyattsville, MD, 2011) 2011, 61:1-7.
• [26]Naugler C, Zhang J, Henne D, Woods P, Hemmelgarn BR: Association of vitamin D status with socio-demographic factors in Calgary, Alberta: an ecological study using Census Canada data. BMC Public Health 2013, 13(1):316. BioMed Central Full Text
• [27]Martini LA, Verly E Jr, Marchioni DM, Fisberg RM: Prevalence and correlates of calcium and vitamin D status adequacy in adolescents, adults, and elderly from the Health Survey-Sao Paulo. Nutrition 2013, 29(6):845-850.
• [28]Borissova AM, Shinkov A, Vlahov J, Dakovska L, Todorov T, Svinarov D, Kassabova L: Vitamin D status in Bulgaria-winter data. Arch Osteoporos 2013, 8(1–2):133.
• [29]Klenk J, Rapp K, Denkinger MD, Nagel G, Nikolaus T, Peter R, Koenig W, Bohm BO, Rothenbacher D: Seasonality of vitamin D status in older people in Southern Germany: implications for assessment. Age Ageing 2013, 42(3):404-408.
• [30]Hill TR, McCarthy D, Jakobsen J, Lamberg-Allardt C, Kiely M, Cashman KD: Seasonal changes in vitamin D status and bone turnover in healthy Irish postmenopausal women. Int J Vitam Nutr Res 2007, 77(5):320-325.
• [31]Lappe JM, Davies KM, Travers-Gustafson D, Heaney RP: Vitamin D status in a rural postmenopausal female population. J Am Coll Nutr 2006, 25(5):395-402.
• [32]Greene-Finestone LS, Berger C, de Groh M, Hanley DA, Hidiroglou N, Sarafin K, Poliquin S, Krieger J, Richards JB, Goltzman D, et al.: 25-Hydroxyvitamin D in Canadian adults: biological, environmental, and behavioral correlates. Osteoporos Int 2011, 22(5):1389-1399.
• [33]Daly RM, Gagnon C, Lu ZX, Magliano DJ, Dunstan DW, Sikaris KA, Zimmet PZ, Ebeling PR, Shaw JE: Prevalence of vitamin D deficiency and its determinants in Australian adults aged 25 years and older: a national, population-based study. Clin Endocrinol (Oxf) 2012, 77(1):26-35.
• [34]Vieth R: Vitamin D supplementation, 25-hydroxyvitamin D concentrations, and safety. Am J Clin Nutr 1999, 69(5):842-856.
• [35]Hypponen E, Turner S, Cumberland P, Power C, Gibb I: Serum 25-hydroxyvitamin D measurement in a large population survey with statistical harmonization of assay variation to an international standard. J Clin Endocrinol Metab 2007, 92(12):4615-4622.
• [36]Kasahara AK, Singh RJ, Noymer A: Vitamin D (25OHD) Serum Seasonality in the United States. PLoS One 2013, 8(6):e65785.
• [37]Bolland MJ, Grey AB, Ames RW, Horne AM, Mason BH, Wattie DJ, Gamble GD, Bouillon R, Reid IR: Age-, gender-, and weight-related effects on levels of 25-hydroxyvitamin D are not mediated by vitamin D binding protein. Clin Endocrinol (Oxf) 2007, 67(2):259-264.
• [38]Jorgensen CS, Christiansen M, Norgaard-Pedersen B, Ostergaard E, Schiodt FV, Laursen I, Houen G: Gc globulin (vitamin D-binding protein) levels: an inhibition ELISA assay for determination of the total concentration of Gc globulin in plasma and serum. Scand J Clin Lab Invest 2004, 64(2):157-166.
• [39]Fang Y, van Meurs JB, Arp P, van Leeuwen JP, Hofman A, Pols HA, Uitterlinden AG: Vitamin D binding protein genotype and osteoporosis. Calcif Tissue Int 2009, 85(2):85-93.
• [40]Nimitphong H, Saetung S, Chanprasertyotin S, Chailurkit LO, Ongphiphadhanakul B: Changes in circulating 25-hydroxyvitamin d according to vitamin D binding protein genotypes after vitamin D3 or D2 supplementation. Nutr J 2013, 12(1):39. BioMed Central Full Text
• [41]Santos BR, Mascarenhas LP, Boguszewski MC, Spritzer PM: Variations in the Vitamin D-Binding Protein (DBP) Gene Are Related to Lower 25-Hydroxyvitamin D Levels in Healthy Girls: A Cross-Sectional Study. Horm Res Paediatr 2013, 79:162-168.
• [42]Perna L, Felix JF, Breitling LP, Haug U, Raum E, Burwinkel B, Schottker B, Brenner H: Genetic variations in the vitamin d binding protein and season-specific levels of vitamin d among older adults. Epidemiology 2013, 24(1):104-109.
• [43]United Stats Census Bureau. U.S. Department of Commerce. American Fact Finder. http://factfinder2.census.gov/faces/nav/jsf/pages/index.xhtml webcite
• [44]Genzen J, Gosselin J: American Society for Clinical Pathology Annual Meeting (Poster Session). Analysis of Vitamin D Send-out Testing at an Academic Medical Center: Understanding Test Utilization and Result Patterns Through Data Mining and Visualization. Am J Clin Pathol 2012, 138:A060.
• [45]Genzen JR, Gosselin JT, Wilson TC, Racila E, Krasowski MD: American Society for Clinical Pathology Annual Meeting (Poster Session). Analysis of Vitamin D Testing at 2 Medical Centers: Population Patterns and Chart Review. Am J Clin Pathol 2013, 140:425.